Open Mic: Next in Health series

Unfortunately, we are already fully booked on site, but we are happy to welcome you online upon registration. If after your online registration you’d like to be included on the waiting list for the on site participation please contact us via events@baselarea.swiss. We will send you a confirmation if a seat becomes available.

Multi-omics technologies are unlocking unprecedented insight into disease biology and enabling a new era of precision drug development. Yet as datasets grow more complex, translating multi-layered biology into confident R&D decisions remains a critical challenge. 

As pharma shifts from single-omics approaches toward integrated, end-to-end platforms, questions of scalability, interoperability and real-world translational impact take center stage.

This Open Mic convenes pharma leaders, platform innovators and translational science experts to examine how multi-omics intelligence is being applied in practice today. The conversation will explore where integrated omics platforms are already delivering measurable value, where hype still outpaces reality and what it truly takes for startups and technology partners to become trusted contributors within pharma R&D.

Our panelists at this event bring deep expertise and diverse perspectives on this topic:

• (Moderator) Dr. Ella Dehghani, Founder & Lead Organiser, Swiss Healthcare Roundtable, EllaVates

• Elodie Pronier, VP Biomedical Discovery, Owkin

• Dr. Abdullah Kahraman, Professor, Data Science in Life Sciences, FHNW

• Dr. Christiaan Klijn, Global Head of Oncology Data Science, Novartis

   

Join us for a candid, strategic discussion on how multi-omics is evolving from promise to platform – and how it can meaningfully shape the next generation of medicines. Register early to avoid missing out!

Participation is free; however, registration is required before 2 Feb 2026 (onsite).